Abstract 15035: Effects on Lipids and Safety Following Cessation of Treatment with Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Antonio M Gotto,Christopher P Cannon,Sukrut Shah,Sherry Liu, Susie Li,Michael E Stepanavage,Eliot A Brinton,Michael H Davidson,Hayes Dansky,Yale B Mitchel,Philip J Barter

Circulation（2011）

引用 27|浏览27

暂无评分

摘要

The cholesteryl ester transfer protein inhibitor anacetrapib was shown to raise high-density lipoprotein (HDL) cholesterol and reduce low-density lipoprotein (LDL) cholesterol, with an acceptable s...

查看译文

关键词

CETP inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要